These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


173 related items for PubMed ID: 6032954

  • 41. [Study of muscle relaxants using evoked electromyography. 2. Characteristic patterns of recovery curve with M-response during effective period of muscle relaxants].
    Suzuki H, Nakagawa H, Kanayama T, Yazaki S.
    Masui; 1970 Dec; 19(13):1455-62. PubMed ID: 5531038
    [No Abstract] [Full Text] [Related]

  • 42. Short-lasting, competitive neuromuscular blocking activity in a series of azobis-arylimidazo-(1,2-a)-pyridinium dihalides.
    Bolger L, Brittain RT, Jack D, Jackson MR, Martin LE, Mills J, Poynter D, Tyers MB.
    Nature; 1972 Aug 11; 238(5363):354-5. PubMed ID: 4627710
    [No Abstract] [Full Text] [Related]

  • 43. [The behavior of serum phosphatides under the influence of muscle relaxants].
    Olthoff D, Kunze D.
    Anaesthesist; 1967 Sep 11; 16(9):280-2. PubMed ID: 4296874
    [No Abstract] [Full Text] [Related]

  • 44. Effects of neuromuscular blocking agents on arterial blood pressure in the rat.
    Jiffry MT.
    Indian J Physiol Pharmacol; 1979 Sep 11; 23(2):133-6. PubMed ID: 489095
    [Abstract] [Full Text] [Related]

  • 45. Gallamine and pancuronium inhibit pre- and postjunctional muscarine receptors in canine saphenous veins.
    Vercruysse P, Bossuyt P, Hanegreefs G, Verbeuren TJ, Vanhoutte PM.
    J Pharmacol Exp Ther; 1979 May 11; 209(2):225-30. PubMed ID: 438998
    [Abstract] [Full Text] [Related]

  • 46. Actions of curare-like agents on the neuromuscular abnormalities caused by an organophosphate in the rat.
    Rump S, Kaliszan A, Edelwejn Z.
    Arch Int Pharmacodyn Ther; 1968 May 11; 173(1):173-81. PubMed ID: 5657817
    [No Abstract] [Full Text] [Related]

  • 47. Affinity of curare-like compounds and their potency in blocking neuromuscular transmission.
    Lu TC.
    J Pharmacol Exp Ther; 1970 Sep 11; 174(3):560-6. PubMed ID: 4247938
    [No Abstract] [Full Text] [Related]

  • 48. [Study of possible changes in curarization according to sex in adult Wistar rats].
    Bouyard P, Gastaut JA, Giudicelli H, Jadot G.
    C R Seances Soc Biol Fil; 1972 Nov 09; 166(2):418-22. PubMed ID: 4267754
    [No Abstract] [Full Text] [Related]

  • 49. The effects of muscle relaxants on auditory evoked potentials in humans.
    Rickards FW, Clark GM, McMahon DS, Dewhurst DJ.
    J Laryngol Otol; 1973 Jul 09; 87(7):647-53. PubMed ID: 4741668
    [No Abstract] [Full Text] [Related]

  • 50. A comparison of the effects of neuromuscular blocking agents and cholinesterase inhibitors on the tibialis anterior and superior rectus muscles of the cat.
    Katz RL, Eakins KE.
    J Pharmacol Exp Ther; 1966 May 09; 152(2):304-12. PubMed ID: 5944372
    [No Abstract] [Full Text] [Related]

  • 51. The clinical use of muscle relaxants.
    Foldes FF.
    Bull Schweiz Akad Med Wiss; 1967 Aug 09; 23(1):5-24. PubMed ID: 6049585
    [No Abstract] [Full Text] [Related]

  • 52. Hemodynamic effects of gallamine and tubocurarine administered during halothane anesthesia.
    Smith NT, Whitcher CE.
    JAMA; 1967 Mar 06; 199(10):704-8. PubMed ID: 6071336
    [No Abstract] [Full Text] [Related]

  • 53. Histamine liberation in surgical patients following administration of neuromuscular blocking drugs.
    Ertama PM.
    Ann Clin Res; 1982 Feb 06; 14(1):15-26. PubMed ID: 6182834
    [Abstract] [Full Text] [Related]

  • 54. Effects of succinylcholine and d-tubocurarine on epinephrine-induced arrhythmias during halothane anesthesia in dogs.
    Tucker WK, Munson ES.
    Anesthesiology; 1975 Jan 06; 42(1):41-4. PubMed ID: 1111370
    [Abstract] [Full Text] [Related]

  • 55. Relative potency of some neuromuscular blocking drugs in vivo and in vitro.
    Anttila P, Ertama P.
    Med Biol; 1978 Jun 06; 56(3):152-5. PubMed ID: 682698
    [Abstract] [Full Text] [Related]

  • 56. The interaction between d-tubocurarine and gallamine during halothane anaesthesia.
    Ghoneim MM, Urgena RB, Dretchen K, Long JP.
    Can Anaesth Soc J; 1972 Jan 06; 19(1):66-74. PubMed ID: 5009451
    [No Abstract] [Full Text] [Related]

  • 57. [Effects of so-called "depolarizing" and "repolarizing" substances on neuromuscular excitability].
    Quevauviller A, Levy JC.
    Anesth Analg (Paris); 1967 Jan 06; 24(2):247-68. PubMed ID: 4383825
    [No Abstract] [Full Text] [Related]

  • 58. Nitroglycerin and the neuromuscular blockade produced by gallamine, succinylcholine, d-tubocurarine, and pancuronium.
    Glisson SN, Sanchez MM, El-Etr AA, Lim RA.
    Anesth Analg; 1980 Feb 06; 59(2):117-22. PubMed ID: 6768318
    [Abstract] [Full Text] [Related]

  • 59. The influence of changes in acid-base balance on neuromuscular blockade in cats.
    Hughes R.
    Br J Anaesth; 1970 Aug 06; 42(8):658-68. PubMed ID: 5485129
    [No Abstract] [Full Text] [Related]

  • 60. Do maternally administered neuromuscular blocking agents interfere with fetal neuromuscular transmission?
    Evans CA, Waud DR.
    Anesth Analg; 1973 Aug 06; 52(4):548-52. PubMed ID: 4352149
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.